Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer

Alì, A., Leibowitz, D., Bhatt, N., Doubrovin, M., Spina, C. S., Bates-Pappas, G. E., Taub, R. N., McKiernan, J. M., Mintz, A., & Molotkov, A. (2022). Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer. European Journal of Nuclear Medicine and Molecular Imaging, 50(3), 692–700. https://doi.org/10.1007/s00259-022-06027-w
Authors:
Alessandra Alì
Dev Leibowitz
Nikunj Bhatt
Mikhail Doubrovin
Catherine S Spina
Gleneara E Bates-Pappas
Robert N Taub
James M McKiernan
Akiva Mintz
Andrei Molotkov
Affiliated Authors:
Alessandra Alì
Dev Leibowitz
Nikunj Bhatt
Mikhail Doubrovin
Catherine S Spina
Robert N Taub
James M McKiernan
Akiva Mintz
Andrei Molotkov
Author Keywords:
bladder cancer
[y-90]dota-biotin-avidin
intravesical radionuclide therapy
avidin
[<sup>90</sup>y]dota-biotin-avidin
[90y]dota-biotin-avidin
Publication Type:
Article
Unique ID:
10.1007/s00259-022-06027-w
PMID:
Publication Date:
Data Source:
PubMed

Record Created: